Amoxicillin
Product Images NDC 50090-0712

9 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Amoxicillin (NDC 50090-0712). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Amoxicillin 875 Hikma 1)

Table 1 (Amoxicillin 875 Hikma 1)
A dosing recommendation table for Amoxicillin detailing usual adult and pediatric doses by infection type and severity for patients over 3 months old. It includes dosages for ear/nose/throat, skin/skin structure, genitourinary tract infections, lower respiratory tract infections, and gonorrhea. Pediatric doses specify weight-based calculations with notes on age and weight considerations.*
FDA Label Image

Chemical Structure (Amoxicillin 875 Hikma 2)

Chemical Structure (Amoxicillin 875 Hikma 2)
Chemical structure diagram showing the molecular formula of Amoxicillin, including its beta-lactam ring, side chains, and three associated water molecules (3H2O). The structure highlights key functional groups of the antibiotic compound.*
FDA Label Image

Table 3 (Amoxicillin 875 Hikma 3)

Table 3 (Amoxicillin 875 Hikma 3)
A data table presenting mean pharmacokinetic parameters of Amoxicillin 400 mg in two dosage forms: 5 mL suspension and 1 chewable tablet. It includes AUC0-∞ (mcg·hr/mL) and Cmax (mcg/mL) values with standard deviations in healthy adults, based on 24 volunteers and dosing at the start of a light meal.*
FDA Label Image

Bacteria (Amoxicillin 875 Hikma 4)

Bacteria (Amoxicillin 875 Hikma 4)
A data table listing bacteria types categorized as Gram-Positive and Gram-Negative. The Gram-Positive column includes Enterococcus faecalis, Staphylococcus spp., Streptococcus pneumoniae, and alpha and beta-hemolytic streptococci. The Gram-Negative column includes Escherichia coli, Haemophilus influenzae, Neisseria gonorrhoeae, Proteus mirabilis, and Helicobacter pylori.*
FDA Label Image

Table 4 (Amoxicillin 875 Hikma 5)

Table 4 (Amoxicillin 875 Hikma 5)
A data table titled 'Susceptibility Test Interpretive Criteria for Amoxicillin,' presenting minimum inhibitory concentration (mcg/mL) and disk diffusion zone diameter (mm) criteria for susceptibility, intermediate resistance, and resistance across various bacterial species relevant to amoxicillin testing.*
FDA Label Image

Table 5 (Amoxicillin 875 Hikma 6)

Table 5 (Amoxicillin 875 Hikma 6)
A data table titled 'Acceptable Quality Control Ranges for Amoxicillin' listing bacteria species, their ATCC numbers, MIC ranges in mcg/mL, and disk diffusion zone ranges in millimeters. It provides quality control parameters for Escherichia coli, Enterococcus faecalis, Haemophilus influenzae, Staphylococcus aureus, and Streptococcus pneumoniae related to amoxicillin.*
FDA Label Image

Table 6 (Amoxicillin 875 Hikma 7)

Table 6 (Amoxicillin 875 Hikma 7)
A data table titled 'H. pylori Eradication Rates When Amoxicillin is Administered as Part of a Triple Therapy Regimen.' It presents eradication rates from two studies under two different analysis methods: Evaluable Analysis and Intent-to-Treat Analysis, with respective confidence intervals and patient numbers specified. Footnotes explain criteria for patient inclusion and dropout handling.*
FDA Label Image

Table 7 (Amoxicillin 875 Hikma 8)

Table 7 (Amoxicillin 875 Hikma 8)
A data table titled 'H. pylori Eradication Rates When Amoxicillin is Administered as Part of a Dual Therapy Regimen' presenting study results. It compares eradication rates from two studies using dual therapy under evaluable and intent-to-treat analyses, showing percentages with 95% confidence intervals and patient numbers. Footnotes explain analysis criteria for patient inclusion and dropout handling.*
FDA Label Image

Label Image (Lbl500900712)

Label Image (Lbl500900712)
Label for Amoxicillin 875 mg tablets by A-S Medication Solutions. The label states 20 tablets per package with NDC 50090-0712-0. Each tablet contains amoxicillin trihydrate equivalent to 875 mg amoxicillin. Manufacturer is Hikma Pharmaceuticals, Amman, Jordan. Storage instructions and safety warnings are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.